
The budget of about 56 billion lek of the Compulsory Health Care Insurance Fund (FSDKSH) was realized to the extent of 99.7% during the past year, where over 12 billion lek were spent only on the reimbursement of medications.
In the structure of the income of FSDKSH, the largest weight is occupied by state budget transfers with 66%, of which 54.6% dedicated to hospital service and 11.4% to primary service, followed by income from health insurance contributions with 33.8 %. Income from other sources has a small specific weight of 0.2%.
Public hospitals are funded more than any other sector. All annual expenses for hospital services reached the value of 30 billion ALL, being realized to the extent of 98.4%, 511 million ALL less than the plan. Of these, 26 billion ALL were spent only on the annual financing of public hospitals to meet the needs in salaries, social security, health, goods and services.
According to the data from the most recent report of the Mandatory Health Care Insurance Fund, reimbursement expenses for 2023 result in over 12 billion ALL, about 60.7 million ALL more than the planned plan. These expenses have increased by 563.9 million ALL compared to 2022.
The increase in reimbursement expenses compared to a year ago was due to treatment with therapy with higher medication costs for patients. All diseases with a high incidence in the population such as Diabetes Mellitus, Hypertension, and others, which have been directly affected by the consequences of Covid-19, have also affected this cause.
During the past year, there was an increase in reimbursement expenses for the group of hospital drugs, and as a percentage of the total reimbursement expenses, a decrease is evident during this year, 1.3% less. Specifically, for the past year reimbursement expenses for hospital drugs accounted for about 30.8%, while for 2022 they accounted for about 32.1% of total reimbursement expenses.
The list of drugs that began its effects in August 2021 was expanded with 22 new drugs, of which 19 drugs are sold in hospital pharmacies and 3 drugs are marketed in open network pharmacies.